BioPharmSignal logoBioPharmSignal

Biotech News

Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences

Senseonics (SENS)SenseonicsCompany update

Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that management will participate in the following investor conferences in November:

Related news

SENSSenseonics2026-09-10 12:00 EST

Senseonics To Participate in Upcoming Institutional Investor Conferences

SENSSenseonics2026-10-21 12:00 EST

Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time

APYXApyx Medical2026-10-21 12:00 EST

Apyx Medical Corporation to Participate in Upcoming Investor Conferences

VKTXViking Therapeutics2026-09-02 20:05 EST

Viking Therapeutics to Participate at Upcoming Investor Conferences

NAMSNewAmsterdam Pharma2026-09-02 12:00 EST

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September

LXRXLexicon Pharmaceuticals2026-09-01 20:05 EST

Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences

BLTEBelite Bio2026-09-01 12:00 EST

Belite Bio to Participate in Four Upcoming Investor Conferences

DCTHDelcath Systems2026-08-31 20:01 EST

Delcath Systems to Participate in Upcoming Investor Conferences

LMATLeMaitre Vascular2026-08-27 20:51 EST

LeMaitre to Participate at Upcoming Investor Conferences in September

LUNGPulmonx2026-08-27 20:05 EST

Pulmonx to Participate in Upcoming Investor Conferences

View all latest news

Senseonics

Implantable Glucose Monitoring Senseonics develops long-term implantable continuous glucose-monitoring systems for people with diabetes. Its technology places a fluorescence-based sensor under the skin rather than relying on frequently replaced transcutaneous sensors. Eversense 365 Eversense 365 is designed to provide up to one year of...

Recent company news

SENSSenseonics2026-10-22 12:00 EST

Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences

SENSSenseonics2026-10-21 12:00 EST

Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time

SENSSenseonics2026-09-14 11:00 EST

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

SENSSenseonics2026-09-10 12:00 EST

Senseonics To Participate in Upcoming Institutional Investor Conferences

SENSSenseonics2026-08-06 20:01 EST

Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results

Stock data

Close
7.97 USD
Market cap
358.63M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States